ArticleNature communications2026
An AI-powered self-driving microscope for low-cost acute leukemia detection.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
29 authors.
Funding
Abstract
Current artificial intelligence systems for leukemia detection typically rely on costly whole-slide scanners, limiting accessibility in low-resource settings. We present ALLocate, a low-cost, artificial intelligence-powered microscope plugin that enables self-driving microscopy for leukemia detection. ALLocate attaches directly to conventional microscopes and provides automated analysis at a fraction of the cost of a whole-slide scanner. We evaluate its robustness at three levels: region-of-interest identification, cell detection, and end-to-end slide-level diagnosis. The system is trained and evaluated using more than 11,000 annotated regions and 130,000 annotated cells and is further validated using independent multi-institutional cohorts, including 165 physical bone marrow smear slides. ALLocate achieves an area under the receiver operating characteristic curve greater than 0.99 for region-of-interest identification, a mean average precision at 50% intersection over union of 0.90 for cell detection, and 88% accuracy for slide-level diagnosis on glass slides without requiring a whole-slide scanner. These results suggest that ALLocate provides an accurate, generalizable, and cost-effective approach for automated bone marrow smear screening, helping bridge the gap between AI innovation and practical deployment in resource-limited settings where access to specialist expertise may be limited.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.